Drug Trial Radar · NCT06807268
A Study of the Medicine Called Abrocitinib in Children 6 to Less Than 12 Years of Age With Moderate-to-Severe Eczema
Last checked: Nov 20, 2026Latest source record: Nov 12, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
151
Actual
Start
Jul 24, 2025
Primary completion
May 2, 2027
Study completion May 2, 2027
Sponsor
- Lead sponsor
- PfizerPfizer (PFE)
- Sponsor type
- Industry
- First posted
- Feb 4, 2025
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, care provider, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 6 years, up to 11 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This research study is being conducted to find out if the test medicine, abrocitinib, improves eczema and is safe for children 6 to \<12 years of age who have moderate-to-severe eczema. Research study participants who meet the study criteria will be assigned by chance (like the flip of a coin) to receive either abrocitinib test medicine or placebo (pretend medicine that looks just like the test medicine) for 16 weeks. The study will last for about 24 weeks in total.
Conditions
- Eczema
Interventions
AbrocitinibDrug
Abrocitinib administered as liquid oral suspension.
PlaceboOther
Placebo administered as liquid oral suspension.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Response based on achieving Validated Investigator's Global Assessment (vIGA) score of clear (0) or almost clear (1) (on a 5-point scale) and a reduction from baseline of ≥2 points at Week 12Time frame: At week 12
- Response based on achieving ≥75% improvement from baseline in the Eczema Area and Severity Index (EASI)-75 at Week 12Time frame: At week 12
Locations
47 sites in 8 countries. Site status is shown where the registry gives one.
Cahaba Dermatology & Skin Health Center, LLC
Birmingham, Alabama
Arkansas Research Trials
North Little Rock, Arkansas
Investigational Drug Service - Rady Childrens Hospital-San Diego
San Diego, California
University of California, San Diego/Rady Children's Hospital-San Diego; Pediatric & Adolescent Derm
San Diego, California
Solutions Through Advanced Research
Jacksonville, Florida
Ada West Research
Meridian, Idaho
Dawes Fretzin Clinical Research Group, LLC
Indianapolis, Indiana
Saint Louis University - Department of Dermatology
St Louis, Missouri
Medical University of South Carolina - Department of Dermatology
Charleston, South Carolina
Medical University of South Carolina - South Carolina Translational Research Nexus Clinic
Charleston, South Carolina
Medical University of South Carolina - Walton Research Building
Charleston, South Carolina
Tribe Clinical Research, LLC
Greenville, South Carolina
Texas Dermatology and Laser Specialists
San Antonio, Texas
Shanghai Children's Hospital
Shanghai, China
Xinhua Hospital Affiliated to Shanghai JiaoTong University School of Medicine
Shanghai, China
Beijing Children's hospital, Capital Medical University
Beijing, Beijing Municipality, China
Shenzhen Children's Hospital
Shenzhen, Guangdong, China
Hunan Children's Hospital
Changsha, Hunan, China
Dermatology Hospital of Jiangxi Province
Nanchang, Jiangxi, China
Shanghai Children's Hospital
Shanghai, Shanghai Municipality, China
Hangzhou Third People's Hospital
Hangzhou, Zhejiang, China
Universitätsklinikum Münster
Münster, North Rhine-Westphalia, Germany
Universitaetsklinikum Carl Gustav Carus, Technischen Universitaet Dresden
Dresden, Saxony, Germany
University of Pecs
Pécs, Hungary
Pécsi Tudományegyetem Klinikai Központ
Pécs, Baranya, Hungary
Trial Pharma Kft.
Békéscsaba, Bekes County, Hungary
Szegedi Tudományegyetem Bőrgyógyászati és Allergológiai Klinika
Szeged, Csongrád-csanád, Hungary
Clinexpert Kft.
Budapest, Pest County, Hungary
Fukuoka National Hospital
Fukuoka, Japan
Saruta Dermatology Clinic
Fukuoka, Japan
Queen's square Medical Facilities Queen's square Dermatology and Allergology
Yokohama, Kanagawa, Japan
Dermatology and Ophthalmology Kume Clinic
Sakai, Osaka, Japan
Sasamoto Children's Clinic
Setagaya-ku, Tokyo, Japan
Servicios Hospitalarios de México S.A. de C.V. (Hospital Angeles Chihuahua)
Chihuahua City, Mexico
Hospital Infantil de México Federico Gómez
Mexico City, Mexico City, Mexico
Eukarya Pharmasite S.C.
Monterrey, Nuevo León, Mexico
Arke SMO S.A. de C.V.
Veracruz, Veracruz, Mexico
Specjalistyczny Gabinet Dermatologiczny Aplikacyjno-Badawczy, Marek Brzewski, Paweł Brzewski spółka cywilna
Krakow, Lesser Poland Voivodeship, Poland
Dermoklinika - Centrum Medyczne spółka cywilna M. Kierstan, J. Narbutt, A. Lesiak
Lodz, Łódź Voivodeship, Poland
LUXDERM Specjalistyczny Gabinet Dermatologiczny prof. dr hab. n. med. Dorota Krasowska
Lublin, Lublin Voivodeship, Poland
Showing 40 of 47 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.